These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 38007248)

  • 1. Ketogenic therapies in Parkinson's disease, Alzheimer's disease, and mild cognitive impairment: An integrative review.
    Price S; Ruppar TM
    Appl Nurs Res; 2023 Dec; 74():151745. PubMed ID: 38007248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ketogenic interventions in mild cognitive impairment, Alzheimer's disease, and Parkinson's disease: A systematic review and critical appraisal.
    Bohnen JLB; Albin RL; Bohnen NI
    Front Neurol; 2023; 14():1123290. PubMed ID: 36846143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. To Keto or Not to Keto? A Systematic Review of Randomized Controlled Trials Assessing the Effects of Ketogenic Therapy on Alzheimer Disease.
    Grammatikopoulou MG; Goulis DG; Gkiouras K; Theodoridis X; Gkouskou KK; Evangeliou A; Dardiotis E; Bogdanos DP
    Adv Nutr; 2020 Nov; 11(6):1583-1602. PubMed ID: 32597927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Ketogenic Diet and Alzheimer's Disease.
    Hersant H; Grossberg G
    J Nutr Health Aging; 2022; 26(6):606-614. PubMed ID: 35718870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A ketogenic drink improves cognition in mild cognitive impairment: Results of a 6-month RCT.
    Fortier M; Castellano CA; St-Pierre V; Myette-Côté É; Langlois F; Roy M; Morin MC; Bocti C; Fulop T; Godin JP; Delannoy C; Cuenoud B; Cunnane SC
    Alzheimers Dement; 2021 Mar; 17(3):543-552. PubMed ID: 33103819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are ketogenic diets promising for Alzheimer's disease? A translational review.
    Lilamand M; Porte B; Cognat E; Hugon J; Mouton-Liger F; Paquet C
    Alzheimers Res Ther; 2020 Apr; 12(1):42. PubMed ID: 32290868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
    Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
    Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive training interventions for dementia and mild cognitive impairment in Parkinson's disease.
    Orgeta V; McDonald KR; Poliakoff E; Hindle JV; Clare L; Leroi I
    Cochrane Database Syst Rev; 2020 Feb; 2(2):CD011961. PubMed ID: 32101639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ketogenic diet rescues cognition in ApoE4+ patient with mild Alzheimer's disease: A case study.
    Morrill SJ; Gibas KJ
    Diabetes Metab Syndr; 2019; 13(2):1187-1191. PubMed ID: 31336463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ketogenic therapy for Parkinson's disease: A systematic review and synthesis without meta-analysis of animal and human trials.
    Grammatikopoulou MG; Tousinas G; Balodimou C; Anastasilakis DA; Gkiouras K; Dardiotis E; Evangeliou AE; Bogdanos DP; Goulis DG
    Maturitas; 2022 Sep; 163():46-61. PubMed ID: 35714419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mild cognitive impairment in Parkinson's disease versus Alzheimer's disease.
    Besser LM; Litvan I; Monsell SE; Mock C; Weintraub S; Zhou XH; Kukull W
    Parkinsonism Relat Disord; 2016 Jun; 27():54-60. PubMed ID: 27089852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a medium-chain triglyceride-based ketogenic formula on cognitive function in patients with mild-to-moderate Alzheimer's disease.
    Ota M; Matsuo J; Ishida I; Takano H; Yokoi Y; Hori H; Yoshida S; Ashida K; Nakamura K; Takahashi T; Kunugi H
    Neurosci Lett; 2019 Jan; 690():232-236. PubMed ID: 30367958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Efficacy of Ketogenic Therapies in the Clinical Management of People with Neurodegenerative Disease: A Systematic Review.
    Dewsbury LS; Lim CK; Steiner GZ
    Adv Nutr; 2021 Jul; 12(4):1571-1593. PubMed ID: 33621313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Comparison of Serial Position Effects in Patients with Mild Cognitive Impairment due to Parkinson's Disease or to Alzheimer's Disease.
    Meyer A; Handabaka I; Ehrensperger MM; Gschwandtner U; Hatz F; Monsch AU; Stieglitz RD; Fuhr P
    Dement Geriatr Cogn Disord; 2020; 49(2):170-178. PubMed ID: 32634809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modified Mediterranean-ketogenic diet modulates gut microbiome and short-chain fatty acids in association with Alzheimer's disease markers in subjects with mild cognitive impairment.
    Nagpal R; Neth BJ; Wang S; Craft S; Yadav H
    EBioMedicine; 2019 Sep; 47():529-542. PubMed ID: 31477562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mild cognitive impairment: when nutrition helps brain energy rescue-a report from the EuGMS 2020 Congress.
    Cunnane SC; Sieber CC; Swerdlow RH; Cruz-Jentoft AJ
    Eur Geriatr Med; 2021 Dec; 12(6):1285-1292. PubMed ID: 34227053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Ketogenic Diet in the Treatment of Neurological Diseases.
    Dyńka D; Kowalcze K; Paziewska A
    Nutrients; 2022 Nov; 14(23):. PubMed ID: 36501033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Ketone Bodies on Brain Metabolism and Function in Neurodegenerative Diseases.
    Jensen NJ; Wodschow HZ; Nilsson M; Rungby J
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33233502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation in mild cognitive impairment due to Parkinson's disease, Lewy body disease, and Alzheimer's disease.
    King E; O'Brien J; Donaghy P; Williams-Gray CH; Lawson RA; Morris CM; Barnett N; Olsen K; Martin-Ruiz C; Burn D; Yarnall AJ; Taylor JP; Duncan G; Khoo TK; Thomas A
    Int J Geriatr Psychiatry; 2019 Aug; 34(8):1244-1250. PubMed ID: 30993722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut mycobiome and its interaction with diet, gut bacteria and alzheimer's disease markers in subjects with mild cognitive impairment: A pilot study.
    Nagpal R; Neth BJ; Wang S; Mishra SP; Craft S; Yadav H
    EBioMedicine; 2020 Sep; 59():102950. PubMed ID: 32861197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.